- Conditions
- Morphea
- Interventions
- Crisaborole
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–13
of 13
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Alopecia Areata
- Interventions
- Crisaborole Topical Ointment, Placebo Topical Ointment
- Drug
- Lead sponsor
- Tufts Medical Center
- Other
- Eligibility
- 2 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Stasis Dermatitis
- Interventions
- crisaborole ointment, vehicle ointment
- Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 4
- States / cities
- El Segundo, California • Lafayette, California • South San Francisco, California + 1 more
- Conditions
- Vitiligo
- Interventions
- Crisaborole 2 % Topical Ointment, PF-07038124 0.01% topical ointment, NBUVB phototherapy, Sham phototherapy, Vehicle
- Drug · Device
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Mild to Moderate Atopic Dermatitis
- Interventions
- Online Treatment response, EUCRISA
- Behavioral · Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 2 Years to 64 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole ointment 2%
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 3 Months to 23 Months
- Enrollment
- 137 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 23
- States / cities
- Hot Springs, Arkansas • San Diego, California • San Francisco, California + 17 more
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole 2% Topical Application Ointment [EUCRISA], Triamcinolone Acetonide 0.1% Ointment
- Drug
- Lead sponsor
- Clinical Research Center of the Carolinas
- Other
- Eligibility
- 2 Years to 79 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Atopic Dermatitis, Eczema
- Interventions
- Crisaborole, Hydrocortisone Ointment, Triamcinolone ointment, Aquaphor
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2024
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Atopic Dermatitis, Eczema
- Interventions
- Crisaborole
- Drug
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Other
- Eligibility
- 4 Months to 17 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1%, Crisaborole Vehicle
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 2 Years and older
- Enrollment
- 237 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 10
- States / cities
- Bryant, Arkansas • Encinitas, California • Orange Park, Florida + 7 more
- Conditions
- Seborrheic Dermatitis
- Interventions
- Crisaborole
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole 2%, Vehicle treatment, Accelerometry device for children, Accelerometry device for adult caregivers
- Drug · Device
- Lead sponsor
- Boston University
- Other
- Eligibility
- 3 Months to 75 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole, Tacrolimus 0.03% Ointment
- Drug
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 2 Years to 15 Years
- Enrollment
- 92 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Rochester, New York